Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home1/sustaiu9/public_html/wp-content/plugins/easy-facebook-likebox/includes/easy-custom-facebook-feed-widget.php:3) in /home1/sustaiu9/public_html/wp-content/plugins/seamless-donations/legacy/dgx-donate.php on line 1009

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home1/sustaiu9/public_html/wp-content/plugins/easy-facebook-likebox/includes/easy-custom-facebook-feed-widget.php:3) in /home1/sustaiu9/public_html/wp-content/plugins/seamless-donations/legacy/dgx-donate.php on line 1009
SSI publications | Sustainable Sciences Institute

 

Selected publications by SSI researchers & collaborators:

Dengue

  • 2015 Andersson, Neil, et al. “Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial.“: h3267.
  • 2015 Weiskopf, et al. Journal of Infectious Disease “Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated with Distinct Patterns of Protein Targets”
  • 2014 Grange, et al. Frontiers in Immunology “Epidemiological Risk Factors Associated with High Global Frequency of Inapparent Dengue Virus Infections”
  • 2014 Waggoner, et al. Journal of Clinical Microbiology “Multiplex Nucleic Acid Amplification Test for Diagnosis of Dengue Fever, Malaria, and Leptospirosis”
  • 2013 Gutiérrez, et alPLoS Neglected Tropical Diseases “Evaluation of the Diagnostic Utility of the Traditional and Revised WHO Dengue Case Definitions”
  • 2011 Gutierrez, et alPLoS Neglected Tropical Diseases “Unusual Dengue Virus 3 Epidemic in Nicaragua, 2009″
  • 2010 Standish,et alPLoS Neglected Tropical Diseases “High Dengue Case Capture Rate in Four Years of a Cohort Study in Nicaragua Compared to National Surveillance Data”
  • 2010 Reyes, et al. Am. J. Trop. Med. Hyg.“Index Cluster Study of Dengue Virus Infection in Nicaragua”
  • 2010 Perez, et al. The Pediatric Infectious Disease Journal “Severe Coinfections of Dengue and Pandemic Infuenza A H1N1 Viruses”
  • 2010 Loke, et alPLoS Neglected Tropical Diseases“Gene expression patterns of dengue virus-infected children from Nicaragua reveal a distinct signature of increased metabolism”
  • 2010 Guzman, et alPLoS Neglected Tropical Diseases“Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis”
  • 2010 Durbin, et al. Virology“Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever”
  • 2010 Balmaseda, et al. The Journal of Infectious Diseases.“Trends in Patterns of Dengue Transmission over 4 Years in a Pediatric Cohort Study in Nicaragua”
  • 2009 Kuan, et al. American Journal of Epidemiology“The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases”
  • 2009 Rocha,et al. Am. J. Trop. Med. Hyg. “Improvement in Hospital Indicators after Changes in Dengue Case Management in Nicaragua”
  • 2008 Balmaseda, et al. Journal of Clinical Virology“Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies”
  • 2007 Colbert, et al. The Pediatric Infectious Disease Journal  “Ultrasound Measurement of Gallbladder Wall Thickening as a Diagnostic Test and Prognostic Indicator for Severe Dengue in Pediatric Patients”
  • 2006 Deen et al. Lancet“The WHO dengue classification and case definitions: time for a reassessment”
  • 2006 Balmaseda, et al. Tropical Medicine and International Health“High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua”
  • 2006 Balmaseda,et al. Am. J. Trop. Med. Hyg. “Serotype-Specific Differences In Clinical Manifestations Of Dengue”
  • 2005 Videa, et al. Clinical And Diagnostic Laboratory Immunology “Immunoglobulin M Enzyme-Linked Immunosorbent Assay Using Recombinant Polypeptides for Diagnosis of Dengue”
  • 2005 Hammond,et al. Am. J. Trop. Med. Hyg. “Differences in Dengue Severity in Infants, Children, and Adults in a 3-Year Hospital-Based Study in Nicaragua”
  • 2005 Balmaseda,et al. Am. J. Trop. Med. Hyg “Short Report: Assessment of The World Health Organization Scheme for Classification of Dengue Severity in Nicaragua”
  • 2003 Messer, et al. Emerging Infectious Diseases“Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus”
  • 2003 Balmaseda, et al. Clinical And Diagnostic Laboratory Immunology “Diagnosis of Dengue Virus Infection by Detection of Specific Immunoglobulin M (IgM) and IgA Antibodies in Serum and Saliva”
  • 2003 Harris, et al. Emerging Infectious Diseases  “Fluid Intake and Decreased Risk for Hospitalization for Dengue Fever, Nicaragua”
  • 2000 Harris,et al. Am. J. Trop. Med. Hyg “Clinical, Epidemiologic, and Virologic Features of Dengue in the 1998 Epidemic in Nicaragua”
  • 2000 Miagostovich, et al. Journal of Clinical Microbiology “Rapid Subtyping of Dengue Virus Serotypes 1 and 4 by Restriction Site-Specific PCR”
  • 1999 Harris, et al Virology“Rapid Subtyping of Dengue Viruses by Restriction Site-Specific (RSS)-PCR”
  • 1999 Balmaseda,et al. Am. J. Trop. Med. Hyg “Application of Molecular Typing Techniques in the 1998 Dengue Epidemic in Nicaragua”
  • 1998 Harris, et alJournal of Clinical Microbiology“Typing of Dengue Viruses in Clinical Specimens and Mosquitoes by Single-Tube Multiplex Reverse Transcriptase PCR”

Influenza

  • 2010 Yozwiak, et al. Journal of Virology “Human Enterovirus 109: a Novel Interspecies Recombinant Enterovirus Isolated from a Case of Acute Pediatric Respiratory Illness in Nicaragua”
  • 2010 Perez, et al. The Pediatric Infectious Disease Journal  “Severe Coinfections of Dengue and Pandemic Influenza A H1N1 Viruses”
  • 2010 Gordon, et al. Clinical Infectious Diseases “Clinical Attack Rate and Presentation of Pandemic H1N1 Influenza versus Seasonal Influenza A and B in a Pediatric Cohort in Nicaragua”
  • 2010 Gordon, et al. PLoS ONE “Diagnostic Accuracy of a Rapid Influenza Test for Pandemic Influenza A H1N1”
  • 2009 Gordon, et al. Emerging Infectious Diseases  “Prevalence and Seasonality of Influenza-like Illness in Children, Nicaragua, 2005–2007”
  • 2009 Gordon, et al. PLoS ONE “Performance of an Influenza Rapid Test in Children in a Primary Healthcare Setting in Nicaragua”

H.I.V.

  • 2014 Lorío, et al. Journal of International Association of Providers of AIDS Care “Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua”

Information Technology

  • 2015 Zornetzer, et al. Proyecto FIRST: Herramientas tecnológicas para vigilancia, manejo y diagnóstico de Dengue. National Science Conference, Managua Nicaragua.
  • 2014 Zornetzer, et al. A low cost ICT Tool Kit for Improved Dengue Surveillance, Laboratory Management and Clinical Decision Support in Nicaragua. American Society of Tropical Medicine and Hygiene 62nd annual meeting, Presentation for session: “Global Health: Technology, Education, Research and Disease Control.” Nov 2-6, New Orleans, LA.
  • 2012 Avilés, et al. Lessons learned in implementing low-cost eHealth tools in Nicaragua: Supporting information collection, management and use in health care delivery and public health research in limited-resource settings. American Society of Tropical Medicine and Hygiene 61st annual meeting, Presentation for session: “Global Health: Technology, Education, Research and Disease Control.” Nov 11-15, Atlanta, GA.
  • 2012 Avilés et al. Evaluation of Low-Cost Open-Source mHealth Tools to Support a Longitudinal Pediatric Dengue and Influenza Cohort Study in Nicaragua: Improving quantity, quality, traceability and timeliness of data collection and management. American Society of Tropical Medicine and Hygiene 61st annual meeting, Poster. Nov 11-15, Atlanta, GA.
  • 2012 Rojas, et al. Latin America eHealth Landscape Analysis: A 10 Country Report on the Status of eHealth in the Region.  Collaborative Research Project funded by the International Research and Development Center of Canada. IDRC Project Reports.
  • 2012 Zornetzer, et al. mHealth Mesa Redonda II: Compartiendo Experiencias en Tecnologías Móviles para Salud en Nicaragua.  Managua, Nicaragua, June 8, 2012.
  • 2011 Zornetzer, H. Potencial de Uso de Tecnologías Móviles en la Salud. Pan American Health Organization/World Health Organization’s regional national nominal computerized vaccine registry workshop, Taller para compartir lessiones aprendidas en el desarrollo e implementación de registros nominales de vacunación nacionales computarizados.  Bogotá, Colombia, Februrary 1-3, 2011.
  • 2011 Zornetzer, H. Data Flow, System Interoperability Issues and Deciding Where/How to Computerize Nominal Registry Data at the National Level. Pan American Health Organization/World Health Organization’s regional national nominal computerized vaccine registry workshop, Taller para compartir lessiones aprendidas en el desarrollo e implementación de registros nominales de vacunación nacionales computarizados. Bogotá, Colombia, Februrary 1-3, 2011.
  • 2010 Zornetzer, et al. 2nda Reunión Latinoamericana de Informática Médica Código Abierto | 2nd Annual Latin American Open Source Health Informatics Meeting, Granada, Nicaragua, 29 Nov – 3 Dec 2010. Meeting and Workshop Outcome Report. December 2010.
  • 2010 Avilés, et al. Tecnologías de Información y Comunicación (TIC) para la Salud Publica. 3r Congreso Nacional de Salud Publica: Determinantes Sociales de la Salud, un enfoque de Salud Publica. Asociación Nicaraguense de Salud Publica. Managua, Nicaragua, December 3, 2010.
  • 2010 Aviles, et al. Tecnologías de Información y Comunicación (TIC) para la Salud: Colaboraciones Multi-institucionales en la Informática Médica en Nicaragua. VI Encuentro Nacional Cientifico en Salud. Managua, Nicaragua, July 23, 2010.
  • 2010 Zornetzer, et al. Research Methods in Impact Evaluation in eHealth and mHealth seminar. University of Bergen Summer Research School 2010. Norway. July 22 – August 2, 2010.
  • 2009 Zornetzer, et al.  Meeting and Workshop Outcome Report.   1ra Reunión Latinoamericana de Informática Médica Código Abierto | 1st Annual Latin American Open Source Health Informatics Meeting, Lima, Perú
  • 2009 Kuan, et al. American Journal of Epidemiology “The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases”
  • 2008 Aviles, et al. Am. J. Trop. Med. Hyg “Quantitative Assessment of the Benefits of Specific Information Technologies Applied to Clinical Studies in Developing Countries”
  • 2008 Coloma, et al.  N.Y. Acad. Sci.  Sustainable Transfer of Biotechnology to Developing Countries: Fighting Poverty by Bringing Scientific Tools to Developing country Partners. 1136: 358–368.
  • 2008 Zornetzer, et al.  Public Health Informatics 2008 Conference, Seattle, WA  Challenges, Opportunities and Lessons Learned: Piloting Multi-Institutional Implementation of Information and Communication Technologies (ICT) for Health in Nicaragua.
  • 2008 Jacakson, et al.  Public Health Informatics 2008 Conference, Seattle, WA  A New Approach to Bridging the Gap Between ICT Software Component Developers and International Development Fieldworkers in the Health Sector.
  • 2007 Aviles, et al. PLoS Medicine “Integration of Information Technologies in Clinical Studies in Nicaragua”

Leishmania

  • 2007 Rodriguez, et al. Parasite Immunology “Atypical cutaneous leishmaniasis cases display elevated antigen-induced interleukin-10”
  • 1999 Belli, et al. Am. J. Trop. Med. Hyg “Widespread Atypical Cutaneous Leishmaniasis Caused By Leishmania (L.Chagasi In Nicaragua”
  • 1998 Harris, et al. Journal of Clinical Microbiology “Single-Step Multiplex PCR Assay for Characterization of New World Leishmania Complexes”
  • 1998 Belli, et al. Am. J. Trop. Med. Hyg “Simplified Polymerase Chain Reaction Detection of New World Leishmania in Clinical Specimens of Cutaneous Leishmaniasis”

Mosquito Vectors

  • 2007 Hammond, et al. Journal of Medical Entomology “Characterization of Aedes aegypti (Diptera: Culcidae) Production Sites in Urban Nicaragua”
  • 2005 Lugo, et al. Journal of the American Mosquito Control Association “Identification of Aedes albopictus in Urban Nicaragua”

Scientific Capacity Building

  • 2009 Harris, Coloma & Zoer The New Humanitarians  “Sustainable Sciences Institute: Developing Scientific Capacity to Address Public Health Needs Worldwide”
  • 2009 Coloma & Harris PLoS Medicine “Molecular Genomic Approaches to Infectious Diseases in Resource-Limited Settings”
  • 2009 Coloma & Harris PloS Biology  “From Construction Workers to Architects: Developing Scientific Research Capacity in Low-Income Countries”
  • 2008 Coloma & Harris New York Academy of Sciences “Sustainable Transfer of Biotechnology to Developing Countries”
  • 2005 Coloma & Harris PLoS Pathogens “Open-Access Science: A Necessity for Global Public Health”
  • 2004 Harris EMBO Reports “Building scientific capacity in developing countries”
  • 2004 Coloma & Harris British Medical Journal “Innovative low cost technologies for biomedical research and diagnosis in developing countries”
  • 2000 Harris & Tanner British Medical Journal “Health technology transfer”
  • 1996 Harris Nature Medicine “Developing essential scientific capability in countries with limited resources”

UC Berkeley

  • 2015 Coloma & Harris Nature Immunology “Broad and Strong: the Ultimate Antibody to Dengue Virus”
  • 2014 Schmid, et al. Frontiers in Immunology “Dendritic Cells in Dengue Virus Infection: Targets of Virus Replication and Mediators of Immunity”
  • 2014 Schmid & Harris PLoS Pathogens “Monocyte Recruitment to the Dermis and Differentiation to Dendritic Cells Increases the Targets for Dengue Virus Replication”
  • 2014 Shepard, et al. PLoS Neglected Tropical Diseases “Approaches to Refining Estimates of Global Burden and Economics of Dengue”
  • 2011 Peña & Harris Journal of Biological Chemistry“Dengue Virus Modulates the Unfolded Protein Response in a Time-dependent Manner”
  • 2010 Beltramello, et al. Cell Host & Microbe “The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity”
  • 2010 Balsitis,et al. PLoS Pathogens “Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification”
  • 2009 Polacek, et al. Journal of General Virology “Poly(A)-binding protein binds to the nonpolyadenylated 3′ untranslated region of dengue virus and modulates translation efficiency” PABP 2009.pdf
  • 2009 Balsitis,et al. Am. J. Trop. Med. Hyg “Tropism of Dengue Virus in Mice and Humans Defined by Viral Nonstructural Protein 3-Specific Immunostaining”
  • 2009 Polacek, et al. Journal of Virology“Conformational Changes in the Solution Structure of the Dengue Virus 5′ End in the Presence and Absence of the 3′ Untranslated Region”
  • 2009 Williams, et al. New York Academy of Sciences “A Mouse Model for Studying Dengue Virus Pathogenesis and Immune Response”
  • 2008 Kyle, et al. Virology“Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model”
  • 2008 Clyde, et al. Virology“The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis”
  • 2008 Kwan, et alPLoS Neglected Tropical Diseases“Dermal-Type Macrophages Expressing CD209/DC-SIGN Show Inherent Resistance to Dengue Virus Growth”
  • 2007 Paranjape & Harris Journal of Biological Chemistry“Y Box-binding Protein-1 Binds to the Dengue Virus 3′-Untranslated Region and Mediates Antiviral Effects” YB-1 2007.pdf
  • 2007 Kyle, et al. Journal of Infectious Diseases “Dengue Virus Infects Macrophages and Dendritic Cells in a Mouse Model of Infection”
  • 2006 Clyde, et al. Journal of Virology“Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis”
  • 2006 Shresta, et al. Journal of Virology“Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability”
  • 2006 Holden, et al. Virology“Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3V stem–loop structure”
  • 2006 Edgil, et al. Journal of Virology“Dengue Virus Utilizes a Novel Strategy for Translation Initiation When Cap-Dependent Translation Is Inhibited”
  • 2006 Clyde & Harris Journal of Virology“RNA Secondary Structure in the Coding Region of Dengue Virus Type 2 Directs Translation Start Codon Selection and Is Required for Viral Replication”
  • 2005 Shresta,et al Journal of Immunology “Critical Roles for Both STAT1-Dependent and STAT1-Independent Pathways in the Control of Primary Dengue Virus Infection in Mice”
  • 2005 Kwan, et al. Journal of Virology“Dendritic Cell Precursors Are Permissive to Dengue Virus and Human Immunodeficiency Virus Infection”
  • 2004 Shresta, et al. Virology“Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice”
  • 2004 Shresta, et al. Journal of Virology“Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical”
  • 2003 Messer, et al. Emerging Infectious Diseases“Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus”
  • 2003 Edgil, et al. Virology “Translation efficiency determines differences in cellular infection among dengue virus type 2 strains”
  • 2002 Diamond, et al. Virology“Mycophenolic Acid Inhibits Dengue Virus Infection by Preventing Replication of Viral RNA”
  • 2001 Diamond & Harris Virology“Interferon Inhibits Dengue Virus Infection by Preventing Translation of Viral RNA through a PKR-Independent Mechanism”
  • 2000 Diamond, et al. Journal of Virology “Infection of Human Cells by Dengue Virus Is Modulated by Different Cell Types and Viral Strains”
  • 2000 Diamond, et al. Journal of Virology “Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons”